EUVIMEDEUVIMED entdecken
Crossref

Oral tranexamic acid for bleeding during spinal surgery: A randomized double-blind placebo clinical trial

Saleh Rasras, Nour Mohammad Mamizadeh, Hossein Safari, Arash Kiani, Zahra Rahimi

AIMS Medical Science · 2020 · 7 (2) · 57-68

DOI: 10.3934/medsci.2020005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AIMS Medical Science, 2020. Verfasst von Saleh Rasras und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to evaluate the oral Tranexamic acid (TXA) effect on the bleeding during spine surgery amounts.







Patients and Methods



In this randomized double-blind placebo clinical trial, patients with lumbar spinal cord and back pain disease, those who needed fusion or were candidates for bilateral or more or equal to two levels surgeries, and those who referred to the Neurosurgery Department, were included and randomly divided into two equal groups. TXA was orally administered at 25 mg/kg dosages four times a day before surgery and 500 mg in the morning of surgery. The bleeding amount during the operation was calculated based on the number of sterile pads used during the operation and the amount of bleeding collected in the suction device (suction) in milliliters. Each sterile pad soaked in blood is equal to 50 ml of bleeding. The suction blood content at the end of the operation (in milliliters), was also collected by bleeding in sterile pads and reported in milliliters. The difference in hemoglobin level 24 after surgery was compared to before surgery. The follow-up period was until discharge from the hospital.

Results

No significant difference was seen in the demographic data between the two groups (p < 0.05). Oral TXA had a positive effect on the intraoperative and postoperative bleeding amounts, and hospitalization duration, and it significantly reduced bleeding in the mentioned cases (p < 0.05 in all cases). Moreover, no significant differences were observed in coagulation factors, including PT, INR, and coagulation tests between the two groups, even PTT was increased. Oral TXA increased nausea and vomiting experienced by patients in the intervention group (p < 0.05).

Conclusions

Overall, oral TXA significantly reduced the intraoperative and postoperative bleeding, as well as the hospitalization duration in patients undergoing spinal surgery in comparison with the placebo group. Because of its anti-fibrinolytic properties, TXA effectively controlled bleeding. Thus, the intraoperative bleeding amount was decreased with the TXA administration.

Zitieren

APA

Rasras, S., Mamizadeh, N. M., Safari, H., Kiani, A., & Rahimi, Z. (2020). Oral tranexamic acid for bleeding during spinal surgery: A randomized double-blind placebo clinical trial. AIMS Medical Science, 7(2), 57-68. https://doi.org/10.3934/medsci.2020005

Vancouver

Rasras S, Mamizadeh NM, Safari H, Kiani A, Rahimi Z. Oral tranexamic acid for bleeding during spinal surgery: A randomized double-blind placebo clinical trial. AIMS Medical Science. 2020;7(2):57-68. doi:10.3934/medsci.2020005

BibTeX
@article{Rasras2020,
  author = {Rasras, Saleh and Mamizadeh, Nour Mohammad and Safari, Hossein and Kiani, Arash and Rahimi, Zahra},
  title = {Oral tranexamic acid for bleeding during spinal surgery: A randomized double-blind placebo clinical trial},
  journal = {AIMS Medical Science},
  year = {2020},
  volume = {7},
  number = {2},
  pages = {57--68},
  doi = {10.3934/medsci.2020005}
}
Kostenlos starten →